Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Molecular, celular and medical aspects of the action of nutraceuticals and small molecules therapeutics: from chemoprevention to new drug development (CROSBI ID 94979)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Čolić, Miroslav ; Pavelić, Krešimir Molecular, celular and medical aspects of the action of nutraceuticals and small molecules therapeutics: from chemoprevention to new drug development // Drugs under experimental and clinical research, 28 (2002), 5; 169-175-x

Podaci o odgovornosti

Čolić, Miroslav ; Pavelić, Krešimir

engleski

Molecular, celular and medical aspects of the action of nutraceuticals and small molecules therapeutics: from chemoprevention to new drug development

Dietary supplements, functional foods and their concentrated, sometimes purified, active forms, the so-called nutraceuticals, are becoming increasingly popular everywhere. Small molecules that regulate signal transduction cascades and gene expression are tested by many pharmaceutical companies. A rapidly and exponentially growing industry (close to $30 billion in 1999 worldwide) exists to commercialise and exploit this interest. However, the scientific basis of action of such unproven products is in the very early stages of development. On the one hand, supporters claim "miracle cures." On the other hand, opponents argue that such unproven agents cause more damage than good.

nutriceutical; molecular mechanisms; chemoprevention

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

28 (5)

2002.

169-175-x

objavljeno

0378-6501

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost